MACROGENICS, INC. Operating Lease, Liability, Noncurrent
MACROGENICS, INC. (MGNX) had Operating Lease, Liability, Noncurrent of $30.12 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2026-08-14
- 2026-06-30: Operating Lease, Liability, Noncurrent $30.12M.
- 2026-03-31: Operating Lease, Liability, Noncurrent $31.30M.
- 2025-12-31: Operating Lease, Liability, Noncurrent $30.60M; Operating Lease, Liability, Noncurrent as first filed $31.59M.
- 2025-09-30: Operating Lease, Liability, Noncurrent $31.87M.
| Period end | Operating Lease, Liability, Noncurrent | Operating Lease, Liability, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $30.12M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $31.30M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $30.60M 10-Q · filed 2026-08-14 | $31.59M 10-K · filed 2026-03-09 |
| 2025-09-30 | $31.87M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $32.13M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $32.10M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $32.60M 10-K · filed 2026-03-09 | |
| 2024-09-30 | $29.36M 10-Q · filed 2024-11-05 | |
| 2024-06-30 | $29.65M 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $29.93M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $30.20M 10-K · filed 2025-03-20 | |
| 2023-09-30 | $30.18M 10-Q · filed 2023-11-06 | |
| 2023-06-30 | $30.16M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $30.13M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $30.11M 10-K · filed 2024-03-07 | |
| 2022-09-30 | $17.00M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $18.26M 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $19.51M 10-Q · filed 2022-05-03 | |
| 2021-12-31 | $20.79M 10-K · filed 2023-03-15 | |
| 2021-09-30 | $22.02M 10-Q · filed 2021-11-02 | |
| 2021-06-30 | $23.21M 10-Q · filed 2021-07-29 | |
| 2021-03-31 | $24.35M 10-Q · filed 2021-04-29 | |
| 2020-12-31 | $25.26M 10-K · filed 2022-02-24 | |
| 2020-09-30 | $24.65M 10-Q · filed 2020-11-04 | |
| 2020-06-30 | $25.65M 10-Q · filed 2020-07-31 | |
| 2020-03-31 | $26.61M 10-Q · filed 2020-05-05 | |
| 2019-12-31 | $27.55M 10-K · filed 2021-02-25 | |
| 2019-09-30 | $28.58M 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $24.28M 10-Q · filed 2019-07-31 | |
| 2019-03-31 | $25.04M 10-Q · filed 2019-05-01 | |
| 2018-12-31 | $0.00 10-K · filed 2020-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |